+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
ID07385573

Evaluation of the Long >150mm Passeo-18 Lux Drug-Coated Balloon for Treating Infrainguinal Artery Blockages in Lower Leg Arteries

Led by KANDO Research · Updated on 2026-09-10

200

Participants Needed

4

Research Sites

208 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the Passeo-18 Lux paclitaxel-releasing percutaneous transluminal angioplasty PTA balloon catheter for treating new or recurring cholesterol-related blockages in the arteries of the lower leg. This device has been previously studied for safety and effectiveness and is approved for use in Europe, meeting European Union safety and performance standards. The trial focuses on gathering additional information about its performance and safety in everyday medical care, especially for longer balloon lengths. All participants in this single-group trial will receive treatment with the Passeo-18 Lux drug-coated balloon, which is available in various sizes. The treatment involves using this balloon catheter during angioplasty to address lesions in the infrainguinal arteries. The study will observe how well the device delivers, inflates, deflates, and is retrieved during the procedure, and will monitor lesion restoration after treatment. Participants will be followed for up to 12 months after the procedure to assess freedom from clinically-driven target lesion revascularization and major adverse events. Additional follow-ups will continue up to 60 months to monitor outcomes like survival without amputation, quality of life changes, walking ability, and lesion patency. Various clinical assessments, questionnaires, and angiograms will be conducted during scheduled visits to evaluate safety and effectiveness over time.

CONDITIONS

Brief Title

A Single Arm Trial to Evaluate the Safety and Efficacy of the Long (> 150mm) PasseoTM-18 LuxTM Drug-coated Balloon in the Treatment of Subjects With Infrainguinal Stenotic, Restenotic or Occlusive Lesions

Research Team

A

Anke Van Roost

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here